StockData
Cellyan Biotechnology Co., Ltd logo

Cellyan Biotechnology Co., Ltd (HKPD) stock

HKPDNasdaqWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends March 31
Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Aug 7, 2026Score 3/30
$1.52−0.09 (-5.30%)

Close on Nov 17, 2026Market cap $24.93MP/E –Yield –

Cellyan Biotechnology total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Cellyan Biotechnology's total debt was $877.90K at Mar 31, 2026. For fiscal 2026 it was $877.90K, down 60.9% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2026Mar 31, 2026$877.90K-60.9%
FY2025Mar 31, 2025$2.25M+68.4%
FY2024Mar 31, 2024$1.33M–

Quarterly total debt

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ1 2026Mar 31, 2026$877.90K–
Q2 FY2026CQ3 2025Sep 30, 2025$2.05M–
Q4 FY2025CQ1 2025Mar 31, 2025$2.25M–
Q4 FY2024CQ1 2024Mar 31, 2024$1.33M–

More Cellyan Biotechnology figures

See a number that looks wrong?